These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25668610)

  • 1. [New therapeutic approaches to pulmonary embolism: trials' results and significance of direct oral anticoagulants].
    Pizarro C; Hammerstingl C; Schaefer C; Grohé C; Nickenig G; Skowasch D
    Pneumologie; 2015 Feb; 69(2):99-110. PubMed ID: 25668610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pulmonary embolism: risk assessment, risk stratification and treatment options.
    Piovella F; Iosub DI
    Clin Respir J; 2016 Sep; 10(5):545-54. PubMed ID: 25619266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management of acute pulmonary embolism. ESC guidelines 2014].
    Saar JA; Maack C;
    Herz; 2015 Dec; 40(8):1048-54. PubMed ID: 26626553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes.
    Meyer G
    Arch Cardiovasc Dis; 2014; 107(6-7):406-14. PubMed ID: 25023859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
    Prandoni P
    Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study.
    Prandoni P
    Eur J Haematol; 2012 Oct; 89(4):281-7. PubMed ID: 22834998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
    Toth PP
    Ann Med; 2014 Sep; 46(6):341-52. PubMed ID: 24888386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of pulmonary embolism.
    Gouin B; Robert-Ebadi H; Righini M; Blondon M
    Expert Opin Pharmacother; 2017 Jan; 18(1):79-93. PubMed ID: 27917690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Review and Update on the Treatment of Acute and Chronic Pulmonary Embolism.
    Shapiro NL; Bhatt SH
    J Pharm Pract; 2016 Feb; 29(1):35-45. PubMed ID: 26589472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study.
    Palla A; Ribas C; Rossi G; Pepe P; Marconi L; Prandoni P
    J Thromb Haemost; 2010 Jan; 8(1):68-74. PubMed ID: 19817998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary embolism hotline 2012. Recent and expected trials.
    Konstantinides S; Lankeit M
    Hamostaseologie; 2013; 33(1):43-50. PubMed ID: 23337923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
    Ageno W; Spyropoulos AC; Turpie AG
    Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.
    Joseph L; Bartholomew JR
    J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):28-39. PubMed ID: 27250719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of chronic pulmonary thromboembolic disease.
    Mendoza V; Scharf ML
    Hosp Pract (1995); 2011 Aug; 39(3):50-61. PubMed ID: 21881392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes.
    Kearon C
    J Thromb Haemost; 2007 Dec; 5(12):2330-5. PubMed ID: 18034763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.